1. Home
  2. Stocks
  3. Advenzymes Share Price
  • Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Advanced Enzyme Technologies Share Price

    Mid Cap
    ₹538.00
    -2.35 (-0.43%)
    18 September, 2024 09:47 BSE: 540025 NSE: ADVENZYMES ISIN: INE837H01020

    Start SIP in Advanced Enzyme Technologies

    Start SIP

    Advanced Enzyme Technologies Performance

    Day Range

    • Low 534
    • High 541
    ₹ 538

    52 Week Range

    • Low 291
    • High 571
    ₹ 538
    • Open Price540
    • Previous Close540
    • Volume66158

    Advanced Enzyme Technologies Chart

    • Over 1 Month + 25.5%
    • Over 3 Month + 36.22%
    • Over 6 Month + 48.7%
    • Over 1 Year + 71.53%

    Advanced Enzyme Technologies Key Statistics

    P/E Ratio 43.4
    PEG Ratio 2.3
    Market Cap Cr
    Price to Book Ratio 4.4
    EPS 11
    Dividend 0.9
    Relative Strength Index 72.67
    Money Flow Index 89.36
    MACD Signal 19.92
    Average True Range 24.56

    Advanced Enzyme Technologies Investment Rating

    • Master Rating:

    • Advanced Enzyme Techs. has an operating revenue of Rs. 631.12 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 30% is great, ROE of 10% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 28% and 43% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 50 which is a POOR score indicating inconsistency in earnings, a RS Rating of 75 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 95 indicates it belongs to a poor industry group of Chemicals-Specialty and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Advanced Enzyme Technologies Financials
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 869291978583
    Operating Expenses Qtr Cr 656367706159
    Operating Profit Qtr Cr 212925272523
    Depreciation Qtr Cr 333333
    Interest Qtr Cr 000000
    Tax Qtr Cr 576666
    Net Profit Qtr Cr 67319186717
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 424321
    Operating Expenses Annual Cr 260237
    Operating Profit Annual in Cr 10575
    Depreciation Cr 1110
    Interest Annual Cr 00
    Tax Annual Cr 2619
    Net Profit Annual Cr 10856
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 5650
    Cash from Investing Activity Annual Cr -7-42
    Cash from Financing Annual Activity Cr -57-12
    Net Cash Flow Annual Cr -8-4
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 580525
    Fixed Assets Annual Cr 164154
    Total Non Current Assets Annual Cr 385387
    Total Current Assets Annual Cr 248189
    Total Assets Annual Cr 633576
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 5247
    ROE Annual % 1911
    ROCE Annual % 2614
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 4527
    IndicatorJun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 155158161158147139
    Operating Expenses Qtr Cr 10310210710710395
    Operating Profit Qtr Cr 515554514444
    Depreciation Qtr Cr 999998
    Interest Qtr Cr 111111
    Tax Qtr Cr 141016131210
    Net Profit Qtr Cr 342842342932
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 661566
    Operating Expenses Annual Cr 419384
    Operating Profit Annual in Cr 204156
    Depreciation Cr 3535
    Interest Annual Cr 32
    Tax Annual Cr 5137
    Net Profit Annual Cr 133106
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 141140
    Cash from Investing Activity Annual Cr -65-298
    Cash from Financing Annual Activity Cr -59-26
    Net Cash Flow Annual Cr 17-184
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 1,3241,235
    Fixed Assets Annual Cr 366350
    Total Non Current Assets Annual Cr 726700
    Total Current Assets Annual Cr 810722
    Total Assets Annual Cr 1,5351,422
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 123115
    ROE Annual % 109
    ROCE Annual % 1411
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3934
    Invest in Advanced Enzyme Technologies

    Advanced Enzyme Technologies Technicals

    EMA & SMA

    Current Price
    ₹538.00
    -2.35 (-0.43%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹481.74
    • 50 Day
    • ₹445.35
    • 100 Day
    • ₹418.19
    • 200 Day
    • ₹390.46
    • 20 Day
    • ₹474.64
    • 50 Day
    • ₹433.09
    • 100 Day
    • ₹405.56
    • 200 Day
    • ₹388.62

    Advanced Enzyme Technologies Resistance and Support

    PIVOT
    ₹544.02
    Resistance
    First Resistance 551.83
    Second Resistance 563.32
    Third Resistance 571.13
    RSI 72.67
    MFI 89.36
    MACD Single Line 19.92
    MACD 28.20
    Support
    First Support 532.53
    Second Support 524.72
    Third Supoort 513.23

    Advanced Enzyme Technologies Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 756,278 32,497,266 42.97
    Week 2,796,002 68,222,439 24.4
    1 Month 1,028,808 31,666,721 30.78
    6 Month 433,107 18,558,619 42.85

    Advanced Enzyme Technologies Result Highlights

    Advanced Enzyme Technologies Synopsis

    NSE-Chemicals-Specialty

    Advanced Enzyme Tech is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 365.47 Cr. and Equity Capital is Rs. 22.37 Cr. for the Year ended 31/03/2024. Advanced Enzyme Technologies Ltd. is a Public Limited Listed company incorporated on 15/03/1989 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24200MH1989PLC051018 and registration number is 051018.
    Market Cap 6,042
    Sales 366
    Shares in Float 6.37
    No of funds 108
    Yield 0.74
    Book Value 10.41
    U/D Vol ratio 4
    LTDebt / Equity
    Alpha 0.16
    Beta 0.83

    Advanced Enzyme Technologies Shareholding Pattern

    Owner NameJun-24Mar-24Dec-23Sep-23
    Promoters 43.02%43.49%43.62%45.92%
    Mutual Funds 5.82%5.5%5.42%5.84%
    Foreign Portfolio Investors 12.03%23.01%22.54%22.27%
    Individual Investors 16.42%15.43%15.9%15.28%
    Others 22.71%12.57%12.52%10.69%

    Advanced Enzyme Technologies Management

    Name Designation
    Mr. Vasant Rathi Non Executive Chairman
    Mr. Mukund M Kabra Whole Time Director
    Ms. Rasika Rathi Non Executive Director
    Dr. Sunny Sharma Non Executive Director
    Mr. Pramod Kasat Independent Director
    Mrs. Vandana Tilak Independent Director
    Ms. Rajshree Patel Independent Director
    Mr. Nitin Desmukh Independent Director
    Mr. Vinodkumar Jajoo Independent Director

    Advanced Enzyme Technologies Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Advanced Enzyme Technologies Corporate Action

    Date Purpose Remarks
    2024-08-10 Quarterly Results
    2024-05-11 Audited Results & Dividend
    2024-02-10 Quarterly Results
    2023-11-07 Quarterly Results
    2023-08-12 Quarterly Results
    Date Purpose Remarks
    2024-07-18 FINAL Rs.1.10 per share(55%)Final Dividend
    2024-05-18 INTERIM Rs.4.00 per share(200%)Interim Dividend
    2023-08-05 FINAL Rs.1.00 per share(50%)Final Dividend
    2023-05-20 INTERIM Rs.4.00 per share(200%)Interim Dividend
    2022-08-12 FINAL Rs.1.00 per share(50%)Final Dividend

    Advanced Enzyme Technologies MF Shareholding

    Name Amount(cr)
    ICICI Prudential Equity & Debt Fund Growth 40,095
    HDFC Small Cap Fund Growth 33,894
    HDFC Multi Cap Fund Regular Growth 17,186
    ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth 4,808
    UTI MNC Fund Regular Plan Growth 3,174

    Advanced Enzyme Technologies FAQs

    What is Share Price of Advanced Enzyme Technologies ?

    Advanced Enzyme Technologies share price is ₹538 As on 18 September, 2024 | 09:33

    What is the Market Cap of Advanced Enzyme Technologies ?

    The Market Cap of Advanced Enzyme Technologies is ₹6016.1 Cr As on 18 September, 2024 | 09:33

    What is the P/E ratio of Advanced Enzyme Technologies ?

    The P/E ratio of Advanced Enzyme Technologies is 43.4 As on 18 September, 2024 | 09:33

    What is the PB ratio of Advanced Enzyme Technologies ?

    The PB ratio of Advanced Enzyme Technologies is 4.4 As on 18 September, 2024 | 09:33

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     
    footer_form

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of ₹10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.